SCHEMBL5158635

SCHEMBL5158635

NC(=O)CC(=O)c1ccc[nH]1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
RAB9A P51151 6/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 3/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
GAA P10253 1/20 0.47
MAPT P10636 2/20 0.45
POLB P06746 1/20 0.45
RECQL P46063 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
THRB P10828 1/20 0.44
GBA1 P04062 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
KDM4E B2RXH2 1/20 0.42
LMNA P02545 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9664550 0.80 TSHR (0.56) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL10676113 0.79
SCHEMBL3699321 0.79
SCHEMBL14436880 0.79 TSHR (0.84) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL5162800 0.77 TSHR (0.53) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL5160589 0.77 TSHR (0.53) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL28053617 0.77 SMN1; SMN2 (0.63) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL13041458 0.77 TSHR (0.53) TSHRRAB9ASMN1; SMN2NPC1MEN1
SCHEMBL6536779 0.77
SCHEMBL18205594 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0751428-B1 Novel image-dye-forming couplers and photographic elements containing them KODAK LTD (GB) 1999-10-06 EP claimed
EP-0751428-A1 Novel image-dye-forming couplers and photographic elements containing them KODAK LIMITED (GB) 1997-01-02 EP claimed
CN-110950845-B Formylacetamide azole derivative and application thereof 聊城大学 2023-04-18 CN disclosed
CN-110950845-A Formylacetamide azole derivative and application thereof 聊城大学 2020-04-03 CN disclosed
US-8293899-B2 Ketone transfer hydrogenation of stereoisomerically enriched 3-heteroaryl-3-oxocarboxylic esters by reducing 3-heteroaryl-3-hydroxycarboxylic esters in the presence of a ruthenium-containing catalyst, an amine and formic acid and/or formates LANXESS DEUTSCHLAND GMBH (DE) 2012-10-23 US disclosed
EP-1340746-B1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives SALTIGO GMBH (DE) 2007-02-28 EP disclosed
US-20030225274-A1 Process for reducing 3-heteroaryl-3-oxopropionic acid derivatives LANXESS DEUTSCHLAND GMBH (DE) 2003-12-04 US disclosed
EP-1340746-A1 Process for the reduction of 3-heteroaryl-3-oxo-propanoic acid derivatives BAYER AG (DE) 2003-09-03 EP disclosed
EP-0751428-B1 Novel image-dye-forming couplers and photographic elements containing them KODAK LTD (GB) 1999-10-06 EP disclosed
US-5919969-A MALONAMIDES EASTMAN KODAK COMPANY (US) 1999-07-06 US disclosed
US-5674667-A COLORFASTNESS; CONTRAST EASTMAN KODAK COMPANY (US) 1997-10-07 US disclosed
US-5674667-A COLORFASTNESS; CONTRAST EASTMAN KODAK COMPANY (US) 1997-10-07 US disclosed
EP-0751428-A1 Novel image-dye-forming couplers and photographic elements containing them KODAK LIMITED (GB) 1997-01-02 EP disclosed
EP-0751428-A1 Novel image-dye-forming couplers and photographic elements containing them KODAK LIMITED (GB) 1997-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030225274-A1 Process for reducing 3-heteroaryl-3-oxopropionic acid derivatives GRHPR, HPD, HAAO TSHR 4474/4885RAB9A 3428/4885SMN1; SMN2 4683/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.